To report SUSPECTED ADVERSE REACTIONS, contact argenx at 1-833-argx411 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Resource Library
To report SUSPECTED ADVERSE REACTIONS, contact argenx at 1-833-argx411 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
To report SUSPECTED ADVERSE REACTIONS, contact argenx at 1-833-argx411 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
To report SUSPECTED ADVERSE REACTIONS, contact argenx at 1-833-argx411 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Resources to inform recognition and diagnosis of CMS
This resource hub brings together key information including diagnostic features, genetic confirmation, specialist referral, and clinical trial opportunities.
Review this resource to explore CMS diagnosis, including clinical signs that raise suspicion, key differential considerations, and the role of genetic testing in confirming the diagnosis
Review this resource for practical guidance on accessing free genetic testing, a service offered by Invitae, including eligibility criteria, how to initiate testing, gene coverage, complimentary genetic counseling for individuals with a positive result, and support for integrating testing into clinical practice
Review this resource to identify CMS specialists accepting referrals, particularly for complex or unclear cases, and for practical guidance on when to refer, key eligibility criteria, referral processes, and key contact details
CMS clinical studies led by argenx
Investigating DOK7-, MuSK-, AGRN-, and LRP4-CMS (NCT06078553)
Explore an overview of CMS, their key clinical features, and common misdiagnoses
Find information on live and virtual events designed to enhance your understanding of CMS and their diagnosis